Steven R. Feldman, MD, PhD, professor of dermatology, Wake Forest School of Medicine, discusses how some drugs for psoriasis are less effective in the presence of metabolic syndrome.
Steven R. Feldman, MD, PhD, professor of dermatology, Wake Forest School of Medicine, discusses how some drugs for psoriasis are less effective in the presence of metabolic syndrome.
TranscriptHow does the presence of metabolic syndrome impact the efficacy of psoriasis treatment?
The presence of metabolic syndrome does affect the efficacy of psoriasis treatments, or at least it’s associated with worse efficacy. So, there was a study done that found people with metabolic syndrome had high rates of failing their treatment for their psoriasis. It may help to use medicines that are either more potent or don’t care whether you have metabolic syndrome.
Are there any data to help clinicians select an effective psoriasis treatment for patients who also have metabolic syndrome?
There are some data that tell us what drug might be more effective for someone with metabolic syndrome. Some of the drugs are dosed based on weight. And for those drugs, the heavier patients do well on a higher dose—and we have the data to support that. Other drugs may not be weight based, and they may have some tendency to be less effective in people who are more obese. One of the drugs, tildrakizumab, had some data showing it worked equally well in patients who either had or did not have metabolic syndrome.
Dr Kathryn Lindley on Pregnancy-Related Cardiovascular Care Gaps and Training Initiatives
December 8th 2023Cardiologists need skills in risk assessment, contraception counseling, and hypertension management for pregnant patients, according to Kathryn Lindley, MD, FACC, Vanderbilt University Medical Center.
Read More
Dr Kathryn Lindley Explains the Importance of Cardio-Obstetrics in Fellowship Programs
December 5th 2023Kathryn Lindley, MD, FACC, Vanderbilt University Medical Center, talks about why it’s important to incorporate cardio-obstetrics training into cardiovascular disease fellowship programs.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Study Finds Link Between Depression, Functional Impairment in Psoriasis, Psoriatic Arthritis
November 24th 2023Depression symptoms are often underdiagnosed and undertreated in patients with psoriasis and psoriatic arthritis, contributing to a worsened quality of life (QOL). However, a recent study found that depression, functional impairment, and worsened QOL are related.
Read More